Jian Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jian Zhang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Zheng Li
Department of Orthopaedics, Zhongshan Hospital of Fudan University, 180 Fenglin Road, Shanghai, China
3 shared publicationsShuhao Liu
Department of Orthopaedics, Zhongshan Hospital of Fudan University, 180 Fenglin Road, Shanghai, China
2 shared publicationsTengfei Fu
Department of Orthopaedics, Zhongshan Hospital of Fudan University, 180 Fenglin Road, Shanghai, China
2 shared publications- Chang Jiang
Department of Clinical Medicine, Shanghai Clinical Research and Trial Center, Shanghai, China
1 shared publication - Ewelina Biskup
Shanghai University of Medicine and Health Sciences, Shanghai, China
1 shared publication - Heng Xu
Department of Plastic and Reconstructive Surgery, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China
1 shared publication
Latest Publications
- Open Access
- 19 May 2021
- Published by Springer Nature in Nano Research
- Vol. 14 (12) , 4901-4902
Erratum to: In vivo and in situ real-time fluorescence imaging of peripheral nerves in the NIR-II window
- 19 May 2021
- Published by Springer Nature in Nano Research
- Vol. 14 (12) , 4901-4902
Open AccessErratum to: In vivo and in situ real-time fluorescence imaging of peripheral nerves in the NIR-II window
- Open Access
- 27 November 2019
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 10 (1) , 1-14
Microtubule destabilization caused by silicate via HDAC6 activation contributes to autophagic dysfunction in bone mesenchymal stem cells
Background: Silicon-modified biomaterials have been extensively studied in bone tissue engineering. In recent years, the toxicity of silicon-doped biomaterials has gradually attracted attention but requires further elucidation. This study was designed to explore whether high-dose silicate can induce a cytotoxicity effect in bone mesenchymal stem cells (BMSCs) and the role of autophagy in its cytotoxicity and mechanism. Methods: Morphologic changes and cell viability of BMSCs were detected after different doses of silicate exposure. Autophagic proteins (LC3, p62), LC3 turnover assay, and RFP-GFP-LC3 assay were applied to detect the changes of autophagic flux following silicate treatment. Furthermore, to identify the potential mechanism of autophagic dysfunction, we tested the acetyl-α-tubulin protein level and histone deacetylase 6 (HDAC6) activity after high-dose silicate exposure as well as the changes in microtubule and autophagic activity after HDAC6 siRNA was applied. Results: It was found that a high dose of silicate could induce a decrease in cell viability; LC3-II and p62 simultaneously increased after high-dose silicate exposure. A high concentration of silicate could induce autophagic dysfunction and cause autophagosomes to accumulate via microtubule destabilization. Results showed that acetyl-α-tubulin decreased significantly with high-dose silicate treatment, and inhibition of HDAC6 activity can restore microtubule structure and autophagic flux. Conclusions: Microtubule destabilization caused by a high concentration of silicate via HDAC6 activation contributed to autophagic dysfunction in BMSCs, and inhibition of HDAC6 exerted a cytoprotection effect through restoration of the microtubule structure and autophagic flux.
- 27 November 2019
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 10 (1) , 1-14
Open AccessMicrotubule destabilization caused by silicate via HDAC6 activation contributes to autophagic dysfunction in bone mesenchymal stem cells
Background: Silicon-modified biomaterials have been extensively studied in bone tissue engineering. In recent years, the toxicity of silicon-doped biomaterials has gradually attracted attention but requires further elucidation. This study was designed to explore whether high-dose silicate can induce a cytotoxicity effect in bone mesenchymal stem cells (BMSCs) and the role of autophagy in its cytotoxicity and mechanism. Methods: Morphologic changes and cell viability of BMSCs were detected after different doses of silicate exposure. Autophagic proteins (LC3, p62), LC3 turnover assay, and RFP-GFP-LC3 assay were applied to detect the changes of autophagic flux following silicate treatment. Furthermore, to identify the potential mechanism of autophagic dysfunction, we tested the acetyl-α-tubulin protein level and histone deacetylase 6 (HDAC6) activity after high-dose silicate exposure as well as the changes in microtubule and autophagic activity after HDAC6 siRNA was applied. Results: It was found that a high dose of silicate could induce a decrease in cell viability; LC3-II and p62 simultaneously increased after high-dose silicate exposure. A high concentration of silicate could induce autophagic dysfunction and cause autophagosomes to accumulate via microtubule destabilization. Results showed that acetyl-α-tubulin decreased significantly with high-dose silicate treatment, and inhibition of HDAC6 activity can restore microtubule structure and autophagic flux. Conclusions: Microtubule destabilization caused by a high concentration of silicate via HDAC6 activation contributed to autophagic dysfunction in BMSCs, and inhibition of HDAC6 exerted a cytoprotection effect through restoration of the microtubule structure and autophagic flux.
- 23 May 2019
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (12) , 23043-23052
MiR‐92b‐3p promotes neurite growth and functional recovery via the PTEN/AKT pathway in acute spinal cord injury
Emerging evidence indicates that microRNAs play an important role in neural remodeling, including neurite growth, after acute spinal cord injury (ASCI). This study aims to identify the mechanism by which miR‐92b‐3p regulates neurite growth in vivo and in vitro. Adult Sprague–Dawley rats were selected to establish the ASCI model, and the expressions of miR‐92b‐3p and phosphate and tensin homolog deleted on chromosome ten (PTEN) were quantified at different time points. The interaction between miR‐92b‐3p and PTEN was further detected in the PC12 cell line and dual‐luciferase reporter assay. Neurite growth proteins (GAP43 and NF‐200) were assessed by western blotting after miR‐92b‐3p mimics treatment. The PTEN/AKT pathway‐related proteins and their roles in miR‐92b‐3p regulation were also identified using western blotting and immunofluorescence in vitro through LY294002, an AKT inhibitor. The effect of miR‐92b‐3p was further determined in vivo according to the Basso‐Beattie‐Bresnahan (BBB) Scale and GAP43 and NF‐200 expressions. miR‐92b‐3p was downregulated after ASCI, while PTEN showed a simultaneous opposing trend. Overexpression of miR‐92b‐3p downregulated PTEN expression and promoted phosphorylation of AKT, as well as the expression of GAP43 and NF‐200 in PC12 cells. Furthermore, the dual‐luciferase reporter assay revealed that miR‐92b‐3p exerted its effect by targeting PTEN's 3ʹ‐untranslated regions and that this effect could be counteracted by AKT phosphorylation blocker LY294002 through western blotting and immunofluorescence. Moreover, miR‐92b‐3p could also improve the BBB scale as well as GAP43 and NF‐200 expression levels in vivo. Collectively, these results indicate that miR‐92b‐3p promotes neurite growth and functional recovery through the PTEN/AKT pathway in ASCI.
- 23 May 2019
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (12) , 23043-23052
MiR‐92b‐3p promotes neurite growth and functional recovery via the PTEN/AKT pathway in acute spinal cord injury
Emerging evidence indicates that microRNAs play an important role in neural remodeling, including neurite growth, after acute spinal cord injury (ASCI). This study aims to identify the mechanism by which miR‐92b‐3p regulates neurite growth in vivo and in vitro. Adult Sprague–Dawley rats were selected to establish the ASCI model, and the expressions of miR‐92b‐3p and phosphate and tensin homolog deleted on chromosome ten (PTEN) were quantified at different time points. The interaction between miR‐92b‐3p and PTEN was further detected in the PC12 cell line and dual‐luciferase reporter assay. Neurite growth proteins (GAP43 and NF‐200) were assessed by western blotting after miR‐92b‐3p mimics treatment. The PTEN/AKT pathway‐related proteins and their roles in miR‐92b‐3p regulation were also identified using western blotting and immunofluorescence in vitro through LY294002, an AKT inhibitor. The effect of miR‐92b‐3p was further determined in vivo according to the Basso‐Beattie‐Bresnahan (BBB) Scale and GAP43 and NF‐200 expressions. miR‐92b‐3p was downregulated after ASCI, while PTEN showed a simultaneous opposing trend. Overexpression of miR‐92b‐3p downregulated PTEN expression and promoted phosphorylation of AKT, as well as the expression of GAP43 and NF‐200 in PC12 cells. Furthermore, the dual‐luciferase reporter assay revealed that miR‐92b‐3p exerted its effect by targeting PTEN's 3ʹ‐untranslated regions and that this effect could be counteracted by AKT phosphorylation blocker LY294002 through western blotting and immunofluorescence. Moreover, miR‐92b‐3p could also improve the BBB scale as well as GAP43 and NF‐200 expression levels in vivo. Collectively, these results indicate that miR‐92b‐3p promotes neurite growth and functional recovery through the PTEN/AKT pathway in ASCI.
- 2 January 2019
- Published by Springer Nature in Biological Trace Element Research
- Vol. 191 (1) , 88-97
High Concentration of Sodium Metasilicate Impairs Autophagic Flux and Induces Apoptosis in Human Umbilical Vein Endothelial Cells
Silicon-doped materials have been widely used in bone regeneration research; however, a consensus on the safety range of silicon ions has not been reached and its toxicity mechanism remains to be further elucidated. This study aims to explore whether high level of sodium metasilicate can induce toxicity effect in human umbilical vein endothelial cells (HUVEC) and the role of autophagy and apoptosis in its toxic mechanism. HUVEC was treated with different level of high silicon and then investigated with respect to morphologic change, cell viability, immunofluorescence, the level of autophagy, and apoptosis-related protein. Moreover, bafilomycin A1 (Baf A1) was applied to detect whether autophagic flux is disrupted, and 3-methyladenine (3-MA, an autophagy inhibitor) was used to determine the relationship between autophagy and apoptosis. Results demonstrated that high-level silicon induced cell viability to decrease; LC3-II, p62, and apoptosis-related proteins were up-regulated after exposure to high-dose silicon (sodium metasilicate concentration more than 1 mM). There is no significant difference in LC3-II and p62 between Baf A1 and sodium metasilicate-exposed group. Besides, 3-MA further increased the apoptotic rate by inhibiting autophagy after high silicon exposure. Collectively, high concentration of silicon can impair autophagy and induce apoptosis in human umbilical vein endothelial cells, and autophagy may play a protective role in HUVEC apoptosis. Furthermore, silicon concentration used in HUVEC should not be more than 1 mM.
- 2 January 2019
- Published by Springer Nature in Biological Trace Element Research
- Vol. 191 (1) , 88-97
High Concentration of Sodium Metasilicate Impairs Autophagic Flux and Induces Apoptosis in Human Umbilical Vein Endothelial Cells
Silicon-doped materials have been widely used in bone regeneration research; however, a consensus on the safety range of silicon ions has not been reached and its toxicity mechanism remains to be further elucidated. This study aims to explore whether high level of sodium metasilicate can induce toxicity effect in human umbilical vein endothelial cells (HUVEC) and the role of autophagy and apoptosis in its toxic mechanism. HUVEC was treated with different level of high silicon and then investigated with respect to morphologic change, cell viability, immunofluorescence, the level of autophagy, and apoptosis-related protein. Moreover, bafilomycin A1 (Baf A1) was applied to detect whether autophagic flux is disrupted, and 3-methyladenine (3-MA, an autophagy inhibitor) was used to determine the relationship between autophagy and apoptosis. Results demonstrated that high-level silicon induced cell viability to decrease; LC3-II, p62, and apoptosis-related proteins were up-regulated after exposure to high-dose silicon (sodium metasilicate concentration more than 1 mM). There is no significant difference in LC3-II and p62 between Baf A1 and sodium metasilicate-exposed group. Besides, 3-MA further increased the apoptotic rate by inhibiting autophagy after high silicon exposure. Collectively, high concentration of silicon can impair autophagy and induce apoptosis in human umbilical vein endothelial cells, and autophagy may play a protective role in HUVEC apoptosis. Furthermore, silicon concentration used in HUVEC should not be more than 1 mM.